100 related articles for article (PubMed ID: 4238722)
21. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
22. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
Huque FT; Box K; Platts JA; Comer J
Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
[TBL] [Abstract][Full Text] [Related]
23. [Drug permeation through synthetic lipoid membranes. 18. The mechanism of ion-pair permeation proton countertransport].
Neubert R; Fürst W; Schleiermacher H
Pharmazie; 1985 Jun; 40(6):426-7. PubMed ID: 4034654
[No Abstract] [Full Text] [Related]
24. Permeation of aromatic organic compounds from aqueous solutions through polyethylene.
Nasim K; Meyer MC; Autian J
J Pharm Sci; 1972 Nov; 61(11):1775-80. PubMed ID: 4652649
[No Abstract] [Full Text] [Related]
25. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems.
Chidambaram N; Burgess DJ
AAPS PharmSci; 2000; 2(3):E28. PubMed ID: 11741244
[TBL] [Abstract][Full Text] [Related]
26. Swelling and binding effects in a polymeric microfiber model for controlled drug release.
Alhaique F; Riccieri FM; Santucci E; Marchetti M
Farmaco Sci; 1983 May; 38(5):309-17. PubMed ID: 6862001
[TBL] [Abstract][Full Text] [Related]
27. Oxygen transmissivity of membranes in contact with the cornea: physiological observations.
Hill RM; Cuklanz H
Br J Physiol Opt; 1967; 24(3):206-16. PubMed ID: 5618628
[No Abstract] [Full Text] [Related]
28. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
29. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Ottaviani G; Martel S; Carrupt PA
J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
[TBL] [Abstract][Full Text] [Related]
30. Nonenzymatic contributions to xenobiotic metabolism.
Testa B
Drug Metab Rev; 1982; 13(1):25-50. PubMed ID: 7044733
[No Abstract] [Full Text] [Related]
31. [Biopartitioning micellar chromatography: its application in evaluating drug membrane transport and activity].
Mao JJ; Sun J; He ZG
Yao Xue Xue Bao; 2005 Oct; 40(10):865-70. PubMed ID: 16408799
[No Abstract] [Full Text] [Related]
32. Electrokinetic migration across artificial liquid membranes Tuning the membrane chemistry to different types of drug substances.
Gjelstad A; Rasmussen KE; Pedersen-Bjergaard S
J Chromatogr A; 2006 Aug; 1124(1-2):29-34. PubMed ID: 16696986
[TBL] [Abstract][Full Text] [Related]
33. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
34. [Improvement in performances of an apparatus testing membrane resorption in vitro, by automatic adjustment and regulation of pH].
Bonnet C; Robert H; Guyot-Hermann AM
J Pharm Belg; 1975; 30(2):121-31. PubMed ID: 1484
[No Abstract] [Full Text] [Related]
35. Experimental and theoretical data on excitable artificial lipidic membranes.
Monnier AM
J Gen Physiol; 1968 May; 51(5):Suppl:26S+. PubMed ID: 5654758
[No Abstract] [Full Text] [Related]
36. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
Fürst W; Neubert R; Richter H; Reppel L
Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
[No Abstract] [Full Text] [Related]
37. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of chlorhexidine, tetracaine and their degradation products by ion-pair liquid chromatography.
Bauer M; Degude C; Mailhe L
J Chromatogr; 1984 Dec; 315():457-64. PubMed ID: 6335513
[No Abstract] [Full Text] [Related]
39. Characterization of drug-membrane interactions using the liposome system.
Tritton TR; Murphere SA; Sarotorelli AC
Biochem Pharmacol; 1977 Dec; 26(24):2319-23. PubMed ID: 597321
[No Abstract] [Full Text] [Related]
40. Proceedings of the 7th Symposium on the Interaction between Biological Membranes and Drugs. Tokyo, November 12-13, 1984. Abstracts.
J Pharmacobiodyn; 1985 May; 8(5):s83-129. PubMed ID: 4045691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
